ES-12

N/A

Report date: 2023/04/25 09:11:30

Base Information

Drug NameES-12
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGlycosylation inhibitors
TargetsImmunoglobulin G
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExocell
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExocell
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A